Control Bionics Ltd (CBL) - Total Liabilities

Latest as of December 2025: AU$2.20 Million AUD ≈ $1.56 Million USD

Based on the latest financial reports, Control Bionics Ltd (CBL) has total liabilities worth AU$2.20 Million AUD (≈ $1.56 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash flow conversion of Control Bionics Ltd to assess how effectively this company generates cash.

Control Bionics Ltd - Total Liabilities Trend (2014–2024)

This chart illustrates how Control Bionics Ltd's total liabilities have evolved over time, based on quarterly financial data. Check financial resilience of Control Bionics Ltd to evaluate the company's liquid asset resilience ratio.

Control Bionics Ltd Competitors by Total Liabilities

The table below lists competitors of Control Bionics Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Hubei Geoway Investment Co Ltd SHG:600462	China	CN¥310.62 Million
Keller Group PLC LSE:KLR	UK	GBX1.15 Billion
Daesung Microbiological Labs. Co. Ltd KQ:036480	Korea	₩22.65 Billion
Aelis Farma SA PA:AELIS	France	€9.46 Million
Evoke Pharma Inc NASDAQ:EVOK	USA	$12.29 Million
Vincit Group Oyj HE:VINCIT	Finland	€23.49 Million
BIT Mining Limited NYSE:BTCM	USA	$14.82 Million
Salee Colour Public Company Limited BK:COLOR	Thailand	฿515.70 Million

Liability Composition Analysis (2014–2024)

This chart breaks down Control Bionics Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see CBL stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.22	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.29	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.22	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Control Bionics Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Control Bionics Ltd (2014–2024)

The table below shows the annual total liabilities of Control Bionics Ltd from 2014 to 2024.

Year	Total Liabilities	Change
2024-12-31	AU$2.72 Million ≈ $1.93 Million	-1.28%
2023-12-31	AU$2.76 Million ≈ $1.95 Million	+74.65%
2022-12-31	AU$1.58 Million ≈ $1.12 Million	+4.47%
2021-12-31	AU$1.51 Million ≈ $1.07 Million	+27.07%
2020-12-31	AU$1.19 Million ≈ $842.14K	+207.54%
2019-12-31	AU$387.00K ≈ $273.83K	+2.98%
2018-12-31	AU$375.80K ≈ $265.90K	+74.08%
2017-12-31	AU$215.88K ≈ $152.75K	-99.98%
2016-12-31	AU$911.31 Million ≈ $644.81 Million	+65.61%
2015-12-31	AU$550.26 Million ≈ $389.35 Million	+18.64%
2014-12-31	AU$463.80 Million ≈ $328.17 Million	--

About Control Bionics Ltd

AU:CBL Australia Medical Devices

Market Cap

$18.95 Million

AU$26.78 Million AUD

Market Cap Rank

#25182 Global

#1106 in Australia

Share Price

AU$0.07

Change (1 day)

+16.07%

52-Week Range

AU$0.03 - AU$0.08

All Time High

AU$1.06